Alembic Pharmaceuticals Ltd (BOM:533573)
₹ 1115.3 -31.2 (-2.72%) Market Cap: 219.23 Bil Enterprise Value: 223.16 Bil PE Ratio: 34.28 PB Ratio: 4.47 GF Score: 91/100

Q1 2021 Alembic Pharmaceuticals Ltd Earnings Call Transcript

Jul 22, 2020 / 11:00AM GMT
Release Date Price: ₹999.35 (+0.47%)
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY '21 Earnings Conference Call of Alembic Pharmaceuticals Limited. On the call today, we have with us Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director Finance and CFO; Mr. Mitanshu Shah, Head Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior VP, Finance.

(Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, sir.

Raj Kumar Shreeram Baheti
Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director

Thank you. This is Raj Kumar Baheti. Good evening, everyone. Thank you all for joining the first quarter results conference call. I'm sure you would have received the results by now. So however, let me briefly take you through the numbers for the quarter ended 30th of June 2020.

So last year, we had closed the year with a strong note, and we are continuing the same journey nicely. First quarter this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot